DRUG.ASX
Betashares Global Healthcare Currency Hedged ETF
https://www.marketindex.com.au/asx/drug/financials
Annual Financial Summary
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
Profitability
NPAT ($)
18,932,000
6,991,000
-
-
NPAT Margin
--
--
-
-
Abnormals ($)
-
-
-
-
NPAT before Abnormals ($)
18,932,000
6,991,000
-
-
Return on Equity (ROE)
10.93%
4.42%
-
-
Return on Assets (ROA)
10.65%
4.24%
-
-
Valuation
PE Ratio
9.45
22.36
-
-
PE Relative to Market
61.3%
153.5%
-
-
Price to Book
1.03
0.99
-
-
Price to Cash Flow
13.49
31.93
-
-
Shares Outstanding (M)
20.30
20.19
-
-
Market Cap ($M)
$178.82
$156.28
-
-
Enterprise Value ($M)
$178.51
$156.17
-
-
Performance
Total Shareholder Return
14.2%
3.4%
-
-
Relative to Market
1.7%
-11.3%
-
-
Per Share
Earnings (EPS Adjusted)
93.27
34.62
-
-
Earnings (with Abnormals)
93.27
34.62
-
-
Cash Flow
(2.10)
36.00
-
-
Cash
0.01
0.01
-
-
Net Tangible Assets
8.54
7.84
-
-
Book Value
8.54
7.84
-
-
Share Price
$8.81
$7.74
-
-
Liquidity
Quick Ratio
0.18
0.18
-
-
Current Ratio
0.18
0.18
-
-
Efficiency
Asset Turnover
0.00
0.00
-
-
Inventory Turnover
-
-
-
-
Working Capital Turnover
0.00
0.00
-
-
Dividends
DPS (c)
24.97
2.62
-
-
Dividend yield
2.83%
-
-
-
Franking
-
-
-
-
Gross DPS (c)
24.97
2.62
-
-
Gross Dividend Yield
2.83%
-
-
-
Payout Ratio
27%
8%
-
-
Member Content
Source:
Annual Financial Income Statement
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
Revenue from Operations
Investment Income
2,647,000
2,675,000
-
-
Other Income
17,237,000
5,266,000
-
-
Expenses
(952,000)
(950,000)
-
-
Profit / Loss before income tax
18,932,000
6,991,000
-
-
Tax Expense
-
-
-
-
NPAT before Abnormals
18,932,000
6,991,000
-
-
Abnormals
-
-
-
-
Abnormals Tax
-
-
-
-
Net Abnormals
-
-
-
-
Outside Equity
-
-
-
-
Preference Dividends
-
-
-
-
Reported NPAT after Abnormals
18,932,000
6,991,000
-
-
EQUITY
Share End
20,297,000
20,191,000
-
-
Share Weighted
20,297,000
20,191,000
-
-
Ordinary Dividends
(5,055,000)
(558,000)
-
-
EPS Adjusted
932,700
346,200
-
-
EPS after Abs
932,749
346,243
-
-
Equity Profit / Loss
-
-
-
-
Member Content
Source:
Annual Financial Balance Sheet
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
CURRENT ASSETS
Cash and Cash Equivalents
0.3
0.11
-
-
Receivables
0.54
0.46
-
-
Investments
-
-
-
-
Other Current Assets
-
-
-
-
Total Current Assets
0.85
0.57
-
-
NON-CURRENT ASSETS
Investments
175.96
160.88
-
-
Property
-
-
-
-
Other Non-Current Assets
1.06
3.59
-
-
Total Non-Current Assets
177.02
164.46
-
-
TOTAL ASSETS
177.87
165.04
-
-
CURRENT LIABILITIES
Creditors
0.08
3.2
-
-
Provisions
4.53
-
-
-
Other Liabilities
0.02
-
-
-
TOTAL CURRENT LIABILITIES
4.63
3.2
-
-
NON-CURRENT LIABILITIES
Borrowings
-
-
-
-
Deferred Tax
-
-
-
-
Other Non-Current Liabilities
0.02
0.04
-
-
TOTAL NON-CURRENT LIABILITIES
0.02
0.04
-
-
TOTAL LIABILITIES
4.65
3.24
-
-
NET ASSETS
182.52
168.28
-
-
Total Equity Attr. to Holders
173.24
158.23
-
-
Outside Equity
-
-
-
-
TOTAL EQUITY
173.24
158.23
-
-
Member Content
Source:
Annual Financial Cash Flow
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
N/A
N/A
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
61.02
79.35
-
-
Payments
(63.82)
(73.72)
-
-
Funds from Operations
-
-
-
-
Dividends Received
2.57
2.47
-
-
Interest Received
-
-
-
-
Interest Paid
(0.01)
-
-
-
Tax Paid
-
-
-
-
Other Operating Cash
(0.18)
(0.82)
-
-
NET CASH FROM OPERATING ACTIVITIES
(0.42)
7.27
-
-
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
-
-
-
-
Payments
-
-
-
-
PP&E
-
-
-
-
Proceeds PP&E
-
-
-
-
Purchase Subsidiary
-
-
-
-
Proceeds Subsidiary
-
-
-
-
Loans Granted
-
-
-
-
Loans Repaid
-
-
-
-
Other Investing Cash
-
-
-
-
NET CASH FROM INVESTING ACTIVITIES
-
-
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
5.79
1.55
-
-
Proceeds from Borrowings
-
-
-
-
Borrowings
-
-
-
-
Dividends Paid
(0.48)
(0.51)
-
-
Other Financing Cash
(4.71)
(8.61)
-
-
NET CASH FROM FINANCING ACTIVITIES
0.61
(7.57)
-
-
NET CHANGE IN CASH
0.19
(0.3)
-
-
CASH AT START
0.11
0.39
-
-
Exchange Rate Adjustment
0.01
0.02
-
-
Other Cash Adjustment
-
-
-
-
CASH AT END
0.3
0.11
-
-
Member Content
Source: